Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

CELIAC DISEASE ANTIBODY SELF-TEST - ANVISA Registration 80464810865

Access comprehensive regulatory information for CELIAC DISEASE ANTIBODY SELF-TEST in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810865 and manufactured by VEDALAB. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including BIOSYNEX SA, CHEMBIO DIAGNOSTICS BRAZIL LTDA., and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
3 Competitors
3 Recent Registrations
80464810865
Registration Details
ANVISA Registration Number: 80464810865
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Registration Details

80464810865

25351733893202319

09377976000152

Company Information

VEDALAB
France
PT: FRANÇA

Dates and Status

Dec 04, 2023

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "CELIAC DISEASE ANTIBODY SELF-TEST"